Variant report
Variant | esv3464264 |
---|---|
Chromosome Location | chr3:140434288-140434840 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:140433649..140435909-chr3:140440994..140443307,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NMNAT3-10 | chr3:140434525-140435054 | refGeneNc_2651_NR_027070 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2649856 | chr3:140434319-140434320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543254821 | chr3:140434335-140434336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2649855 | chr3:140434340-140434341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2649854 | chr3:140434357-140434358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561555386 | chr3:140434402-140434403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2649853 | chr3:140434417-140434418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533038806 | chr3:140434422-140434423 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376114941 | chr3:140434440-140434441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573455709 | chr3:140434441-140434442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186150772 | chr3:140434445-140434446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs200056896 | chr3:140434451-140434452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs66461775 | chr3:140434452-140434453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200318493 | chr3:140434453-140434454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201305309 | chr3:140434454-140434455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs62268353 | chr3:140434455-140434456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs62268354 | chr3:140434468-140434469 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs62268355 | chr3:140434471-140434472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192418571 | chr3:140434507-140434508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs180806713 | chr3:140434518-140434519 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371782479 | chr3:140434531-140434532 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs186246444 | chr3:140434532-140434533 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs373773464 | chr3:140434546-140434547 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs2583814 | chr3:140434556-140434557 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs375755386 | chr3:140434558-140434559 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs36216293 | chr3:140434596-140434597 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs36214668 | chr3:140434622-140434623 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs372592212 | chr3:140434640-140434641 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs861396 | chr3:140434648-140434649 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs533198846 | chr3:140434677-140434678 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs369959345 | chr3:140434702-140434703 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs371578090 | chr3:140434776-140434777 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 16740712 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 17989066 | CNVD |
Cancer | 21129771 | CNVD |
Ovarian cancer | 23621864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:140428000-140436600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr3:140428600-140435600 | Weak transcription | Pancreas | Pancrea |
3 | chr3:140431600-140437200 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr3:140431800-140435200 | Weak transcription | GM12878-XiMat | blood |
5 | chr3:140433400-140435200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
6 | chr3:140434000-140435200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr3:140434000-140435200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr3:140434000-140438200 | Weak transcription | HepG2 | liver |
9 | chr3:140434200-140435200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr3:140434200-140435200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr3:140434200-140435200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
12 | chr3:140434200-140439200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr3:140434400-140435600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |